TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117.

Mikkael A Sekeres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.